Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Neoplasms"" wg kryterium: Temat


Tytuł :
A rare case of duodenal neuroendocrine tumor with hepatic metastasis.
Autorzy :
Li J; Department of Gastroenterology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Huang WF; Department of Gastroenterology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Zhang JY; Department of Gastroenterology, The First Affiliated Hospital of Xiamen University, Xiamen, China. Electronic address: .
Pokaż więcej
Źródło :
Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2022 Mar; Vol. 46 (3), pp. 101850. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Duodenal Neoplasms*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/pathology
Neuroendocrine Tumors*/pathology
Pancreatic Neoplasms*
Humans ; Intestinal Neoplasms ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
A rare gastric lesion: diminutive, well-differentiated, Grade 3, type 3 gastric neuroendocrine tumor with extremely high ki-67 index removed en bloc under endoscopy.
Autorzy :
Zhu C; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Kawachi H; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Lu X; Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China. .
Pokaż więcej
Źródło :
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2022 May; Vol. 25 (3), pp. 659-664. Date of Electronic Publication: 2022 Feb 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Adult ; Endoscopy, Gastrointestinal ; Gastric Mucosa/pathology ; Humans ; Intestinal Neoplasms ; Ki-67 Antigen/analysis ; Male ; Pancreatic Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.
Autorzy :
Tabernero J; Medical Oncology Department - Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain. Electronic address: .
Andre F; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
Blay JY; Centre Léon Bérard, Lyon, France.
Bustillos A; Global Product Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Fear S; Global Product Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Ganta S; Product Development Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Jaeger D; Medical Oncology Department, Heidelberg University Hospital (UKHD), Heidelberg, Germany.
Maio M; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
Melero I; Centre of Applied Medical Research, University Clinic of Navarra, Navarra, Spain.
Pokaż więcej
Źródło :
ESMO open [ESMO Open] 2022 Apr; Vol. 7 (2), pp. 100419. Date of Electronic Publication: 2022 Mar 16.
Typ publikacji :
Clinical Trial, Phase II; Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized*/adverse effects
Neoplasms*/drug therapy
Neoplasms*/pathology
Adolescent ; Adult ; Female ; Humans ; Thymoma ; Thymus Neoplasms ; Thyroid Cancer, Papillary ; Thyroid Neoplasms ; Uterine Cervical Neoplasms
Czasopismo naukowe
Tytuł :
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
Autorzy :
Heinze K; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Nazeran TM; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Lee S; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.
Krämer P; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Cairns ES; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
Chiu DS; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Leung SC; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Kang EY; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.
Meagher NS; University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, Australia.; University of New South Wales, School of Women's and Children's Health, Sydney, Australia.
Kennedy CJ; The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.
Boros J; The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.
Kommoss F; Medizin Campus Bodensee, Institute of Pathology, Friedrichshafen, Germany.
Vollert HW; Department of Gynecology and Obstetrics, Medizin Campus Bodensee, Friedrichshafen, Germany.
Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
du Bois A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.
Grube M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Kraemer B; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Staebler A; University Hospital Tübingen, Institute of Pathology and Neuropathology, Tübingen, Germany.
Kommoss FK; University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany.
Heublein S; Department of Obstetrics and Gynecology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany.
Sinn HP; University Hospital Heidelberg, Institute of Pathology, Heidelberg, Germany.
Singh N; Department of Pathology, Barts Health National Health Service Trust, London, UK.
Laslavic A; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Elishaev E; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Olawaiye A; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Moysich K; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Modugno F; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sharma R; Westmead Hospital, Tissue Pathology and Diagnostic Oncology, Sydney, Australia.; University of Sydney, Sydney, Australia.; Western Sydney University, Sydney, Australia.
Brand AH; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.
Harnett PR; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia.
DeFazio A; The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, Australia.
Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Lener M; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Tołoczko-Grabarek A; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Cybulski C; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Gronwald H; Department of Propaedeutics, Physical Diagnostics and Dental Physiotherapy, Pomeranian Medical University, Szczecin, Poland.
Gronwald J; Department of Genetics and Pathology, International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland.
Coulson P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
El-Bahrawy MA; Department of Metabolism, Digestion and Reproduction, Hammersmith Hospital, Imperial College London, London, UK.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Gorringe KL; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre, Women's Cancer Program, Melbourne, Australia.
Campbell I; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre, Cancer Genetics Laboratory, Research Division, Melbourne, Australia.
Cook L; Division of Epidemiology and Biostatistics, The University of New Mexico, Albuquerque, NM, USA.
Gayther SA; Cedars-Sinai Medical Center, Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Los Angeles, CA, USA.
Carney ME; Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Shvetsov YB; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
Hernandez BY; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
Wilkens LR; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
Goodman MT; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA, USA.
Mateoiu C; Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Gothenburg, Sweden.
Linder A; Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Gothenburg, Sweden.
Sundfeldt K; Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska Center for Cancer Research, Gothenburg, Sweden.
Kelemen LE; Hollings Cancer Center and Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Gentry-Maharaj A; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; University College London, Department of Women's Cancer, Institute for Women's Health, London, UK.
Widschwendter M; University of Innsbruck, EUTOPS Institute, Innsbruck, Austria.
Menon U; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.
Bolton KL; Department of Hematology and Oncology, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Shah M; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
Jimenez-Linan M; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Brenton JD; University of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK.
Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Doherty JA; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
Gilks B; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Ghatage P; Department of Oncology, Division of Gynecologic Oncology, University of Calgary, Calgary, Canada.
Huntsman DG; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Nelson GS; Department of Oncology, Division of Gynecologic Oncology, University of Calgary, Calgary, Canada.
Tinker AV; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.; Department of Medicine, University of British Columbia, Vancouver, Canada.
Lee CH; University of Alberta, Department of Laboratory Medicine and Pathology, Edmonton, Canada.
Goode EL; Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
Nelson BH; Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, Canada.
Ramus SJ; University of New South Wales, Adult Cancer Program, Lowy Cancer Research Centre, Sydney, Australia.; University of New South Wales, School of Women's and Children's Health, Sydney, Australia.
Kommoss S; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
Talhouk A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.
Anglesio MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.; University of British Columbia, Vancouver General Hospital, and BC Cancer. British Columbia's Gynecological Cancer Research Team (OVCARE), Vancouver, Canada.
Pokaż więcej
Źródło :
The Journal of pathology [J Pathol] 2022 Apr; Vol. 256 (4), pp. 388-401. Date of Electronic Publication: 2022 Feb 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma*
Endometriosis*/genetics
Endometriosis*/pathology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Brain Neoplasms ; CD8-Positive T-Lymphocytes/pathology ; Canada ; Colorectal Neoplasms ; DNA-Binding Proteins/genetics ; Female ; Humans ; Neoplastic Syndromes, Hereditary ; Nuclear Proteins/genetics ; Prognosis ; Transcription Factors/genetics
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
ASO Author Reflections: Adjuvant Chemotherapy Should not be Omitted for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability.
Autorzy :
Nie R; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Kim JW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Chen G; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Li YF; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2022 Apr; Vol. 29 (4), pp. 2332-2333. Date of Electronic Publication: 2021 Nov 11.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Neoplastic Syndromes, Hereditary*
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Brain Neoplasms ; Chemotherapy, Adjuvant ; Colorectal Neoplasms ; Humans ; Microsatellite Instability
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.
Autorzy :
Harrow B; Ipsen, Cambridge, MA, USA.
Fagnani F; CEMKA, Bourg-la-Reine, France.
Nevoret C; CEMKA, Bourg-la-Reine, France.
Truong-Thanh XM; Ipsen, Boulogne-Billancourt, France.
de Zélicourt M; CEMKA, Bourg-la-Reine, France.
de Mestier L; Department of Gastroenterology-Pancreatology, Beaujon Hospital (APHP), Université de Paris, 100 bd du Général Leclerc, 92100, Clichy, France. .
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2022 Apr; Vol. 39 (4), pp. 1754-1771. Date of Electronic Publication: 2022 Feb 22.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Neuroendocrine Tumors*/drug therapy
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Adolescent ; Adult ; Cohort Studies ; Humans ; Intestinal Neoplasms ; Peptides, Cyclic ; Retrospective Studies ; Somatostatin ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
Autorzy :
Nie RC; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Chen GM; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yuan SQ; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Kim JW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Zhou J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Nie M; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Feng CY; Department of Information, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Chen YB; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Chen S; Department of Gastrointestinal Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Zhou ZW; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. .
Wang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. .
Li YF; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2022 Apr; Vol. 29 (4), pp. 2324-2331. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Microsatellite Instability*
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Brain Neoplasms ; Chemotherapy, Adjuvant ; Colorectal Neoplasms ; DNA Mismatch Repair ; Humans ; Neoplasm Staging ; Neoplastic Syndromes, Hereditary ; Prognosis
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.
Autorzy :
Rajagopal T; Cancer Genomics Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur, 613 401, India.
Seshachalam A; Department of Medical and Paediatric Oncology, Dr.G.V.N Cancer Institute, Singarathope, Trichy, 620 008, India.
Jothi A; Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur, 613 401, India.
Rathnam KK; Department of Hemato Oncology - Medical Oncology and Bone Marrow Transplantation, Meenakshi Mission Hospital & Research Centre, Madurai, 625 107, India.
Talluri S; Dana Farber Cancer Institute, Boston, MA, 02215, USA.; Veterans Administration Boston Healthcare System, West Roxbury, MA, 02132, USA.
Venkatabalasubranian S; Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, Tamil Nadu, 603 203, India.
Dunna NR; Cancer Genomics Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur, 613 401, India. .
Pokaż więcej
Źródło :
Molecular biology reports [Mol Biol Rep] 2022 Apr; Vol. 49 (4), pp. 3025-3032. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji :
Journal Article
MeSH Terms :
BRCA1 Protein*/genetics
BRCA2 Protein*/genetics
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/pathology
Breast Neoplasms/genetics ; Female ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Germ-Line Mutation/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Ovarian Neoplasms/genetics
Czasopismo naukowe
Tytuł :
Primary ovarian carcinoid arising in associated mature cystic teratoma.
Autorzy :
Zhang W; Department of Pathology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuhan, 430071, Hubei Province, People's Republic of China.
Chen Q; Department of Pathology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuhan, 430071, Hubei Province, People's Republic of China. .
Pokaż więcej
Źródło :
BMC women's health [BMC Womens Health] 2022 Mar 17; Vol. 22 (1), pp. 76. Date of Electronic Publication: 2022 Mar 17.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoid Tumor*/diagnostic imaging
Carcinoid Tumor*/surgery
Neuroendocrine Tumors*
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/surgery
Teratoma*/diagnosis
Teratoma*/pathology
Teratoma*/surgery
Female ; Humans ; Intestinal Neoplasms ; Middle Aged ; Pancreatic Neoplasms ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Mismatch repair deficiency in early-onset duodenal, ampullary, and pancreatic carcinomas is a strong indicator for a hereditary defect.
Autorzy :
Kryklyva V; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Brosens LA; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Marijnissen-van Zanten MA; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Ligtenberg MJ; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Nagtegaal ID; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
The journal of pathology. Clinical research [J Pathol Clin Res] 2022 Mar; Vol. 8 (2), pp. 181-190. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma*
Colorectal Neoplasms, Hereditary Nonpolyposis*/diagnosis
Colorectal Neoplasms, Hereditary Nonpolyposis*/epidemiology
Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics
Brain Neoplasms ; Colorectal Neoplasms ; DNA Mismatch Repair/genetics ; Humans ; Middle Aged ; Neoplastic Syndromes, Hereditary ; Retrospective Studies
SCR Disease Name :
Turcot syndrome
Czasopismo naukowe
Tytuł :
Cyst(e)inase-Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer.
Autorzy :
Kerimoglu B; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
Lamb C; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas.
McPherson RD; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
Ergen E; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
Stone EM; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas.
Ooi A; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.; University of Arizona Cancer Center, Tucson, Arizona.
Pokaż więcej
Źródło :
Molecular cancer therapeutics [Mol Cancer Ther] 2022 Mar 01; Vol. 21 (3), pp. 419-426.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/genetics
Cysts*
Ferroptosis*
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/genetics
Animals ; Cysteine/metabolism ; Female ; Humans ; Leiomyomatosis ; Male ; Mice ; Neoplastic Syndromes, Hereditary ; Sirolimus/pharmacology ; Skin Neoplasms ; Uterine Neoplasms
SCR Disease Name :
Hereditary leiomyomatosis and renal cell cancer
Czasopismo naukowe
Tytuł :
Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
Autorzy :
Shannon AB; From the Department of Surgery (Shannon, Straker), Hospital of the University of Pennsylvania, Philadelphia, PA.
Straker RJ 3rd; From the Department of Surgery (Shannon, Straker), Hospital of the University of Pennsylvania, Philadelphia, PA.
Fraker DL; Division of Endocrine and Oncologic Surgery, Department of Surgery (Fraker, Miura, Karakousis), Hospital of the University of Pennsylvania, Philadelphia, PA.
Miura JT; Division of Endocrine and Oncologic Surgery, Department of Surgery (Fraker, Miura, Karakousis), Hospital of the University of Pennsylvania, Philadelphia, PA.
Karakousis GC; Division of Endocrine and Oncologic Surgery, Department of Surgery (Fraker, Miura, Karakousis), Hospital of the University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
Journal of the American College of Surgeons [J Am Coll Surg] 2022 May 01; Vol. 234 (5), pp. 900-909.
Typ publikacji :
Journal Article
MeSH Terms :
Intestinal Neoplasms*/surgery
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Pancreatic Neoplasms*/pathology
Pancreatic Neoplasms*/surgery
Aged ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymphatic Metastasis/pathology ; Prognosis ; Retrospective Studies ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors.
Autorzy :
Murphy ES; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
Dhall G; UAB Division of Pediatric Hematology, Oncology, and Blood & Marrow Transplantation, Children's of Alabama at University of Alabama at Birmingham, Birmingham, Alabama.
Fangusaro J; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Aflac Cancer Center, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia.
Bartels U; Division of Haematology/Oncology, Neuro-Oncology, The Hospital for Sick Children, Toronto, Canada.
Fouladi M; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Shaw D; Department of Radiology, Seattle Children's Hospital, Seattle, Washington.
Khatua S; Department of Pediatrics, Neuro Oncology, MD Anderson Cancer Center, Houston, Texas.
Hughes CW; Operations Center, Children's Oncology Group, Monrovia, California.
Panigraphy A; Department of Diagnostic Imaging, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania.
Ioakeim-Ioannidou M; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Souweidane M; Department of Neurological Surgery, Weill Cornell Medical College and Memorial Sloan-Kettering Cancer Center, New York, New York.
Morris D; Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Gajjar A; Departments of Oncology, Brigham and Women's Hospital and Boston Children's Hospital, Boston, Massachusetts.
Wu S; Departments of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Onar-Thomas A; Departments of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Haas-Kogan DA; Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women's Hospital and Boston Children's Hospital, Boston, Massachusetts.
MacDonald SM; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 May 01; Vol. 113 (1), pp. 143-151. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Central Nervous System Neoplasms*/pathology
Central Nervous System Neoplasms*/radiotherapy
Neoplasms, Germ Cell and Embryonal*/drug therapy
Neoplasms, Germ Cell and Embryonal*/radiotherapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Central Nervous System/pathology ; Child ; Combined Modality Therapy ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/drug therapy ; Prospective Studies ; Radiation Dosage ; Testicular Neoplasms
SCR Disease Name :
Nonseminomatous germ cell tumor
Czasopismo naukowe
Tytuł :
Secretory Carcinoma of the Salivary Gland: A Rarity in Children.
Autorzy :
Kelly GA; Baylor College of Medicine.
Venkatramani R; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center.
Quintanilla NM; Departments of Pathology and Immunology.
Chelius DC; Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, TX.
Roy A; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center.; Departments of Pathology and Immunology.
Mahajan P; Division of Hematology/Oncology, Department of Pediatrics, Texas Children's Cancer Center.
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2022 May 01; Vol. 44 (4), pp. 167-172. Date of Electronic Publication: 2021 Sep 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma*/genetics
Mammary Analogue Secretory Carcinoma*/genetics
Mammary Analogue Secretory Carcinoma*/pathology
Mammary Analogue Secretory Carcinoma*/therapy
Salivary Gland Neoplasms*/genetics
Salivary Gland Neoplasms*/pathology
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/surgery
Biomarkers, Tumor/genetics ; Breast Neoplasms ; Child ; Humans ; Oncogene Proteins, Fusion/genetics ; Salivary Glands/pathology
SCR Disease Name :
Secretory breast carcinoma
Czasopismo naukowe
Tytuł :
Association between Alzheimer's disease and risk of cancer: A retrospective cohort study in Shanghai, China.
Autorzy :
Ren RJ; Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huang Q; Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu G; School of Public Health, Shanghai Jiao Tong University, Shanghai, China.
Gu K; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Dammer EB; Department of Biochemistry and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia, USA.
Wang CF; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Xie XY; Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen W; Information Center, Shanghai Municipal Commission of Health, Shanghai, China.
Shao ZY; Information Center, Shanghai Municipal Commission of Health, Shanghai, China.
Chen SD; Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang G; Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2022 May; Vol. 18 (5), pp. 924-933. Date of Electronic Publication: 2021 Sep 05.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease*/epidemiology
Lung Neoplasms*
Testicular Neoplasms*
China/epidemiology ; Humans ; Male ; Neoplasms, Germ Cell and Embryonal ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors
SCR Disease Name :
Testicular Germ Cell Tumor
Czasopismo naukowe
Tytuł :
Role of [ F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors.
Autorzy :
Magi L; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, 00189, Rome, Italy.; Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Rome, Italy.
Prosperi D; Nuclear Medicine Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, 00189, Rome, Italy.
Lamberti G; Department of Experimental Diagnostic and Specialized Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Marasco M; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, 00189, Rome, Italy.
Ambrosini V; Department of Experimental Diagnostic and Specialized Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Rinzivillo M; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, 00189, Rome, Italy.
Campana D; Department of Experimental Diagnostic and Specialized Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Division of Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Gentiloni G; Nuclear Medicine Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, 00189, Rome, Italy.
Annibale B; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, 00189, Rome, Italy.; Department of Medical-Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Signore A; Nuclear Medicine Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, 00189, Rome, Italy.; Department of Medical-Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Panzuto F; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, 00189, Rome, Italy. .; Department of Medical-Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. .
Pokaż więcej
Źródło :
Endocrine [Endocrine] 2022 May; Vol. 76 (2), pp. 484-490. Date of Electronic Publication: 2022 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors*/pathology
Organometallic Compounds*/therapeutic use
Pancreatic Neoplasms*/pathology
Fluorodeoxyglucose F18 ; Humans ; Intestinal Neoplasms ; Positron Emission Tomography Computed Tomography ; Retrospective Studies ; Stomach Neoplasms
SCR Disease Name :
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Tytuł :
Novel RGAG1-BCOR gene fusion revealed in a somatic soft tissue sarcoma with a long follow-up.
Autorzy :
Vasella M; Department of Plastic Surgery and Hand Surgery, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. .
Wagner U; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Fritz C; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Seidl K; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Giudici L; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Exner GU; Orthopaedie Zentrum Zuerich, Ozz, Zurich, Switzerland.
Moch H; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Wild PJ; Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt, Germany.
Bode-Lesniewska B; Pathology Institute Enge and University of Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 May; Vol. 480 (5), pp. 1107-1114. Date of Electronic Publication: 2021 Jul 31.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Bone Neoplasms*/pathology
Sarcoma*/pathology
Soft Tissue Neoplasms*/genetics
Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Chondrosarcoma ; Follow-Up Studies ; Gene Fusion ; Humans ; Male ; Middle Aged ; Neoplasms, Connective and Soft Tissue ; Oncogene Proteins, Fusion/genetics ; Proto-Oncogene Proteins/genetics ; Repressor Proteins/genetics ; Retrospective Studies
SCR Disease Name :
Chondrosarcoma, Extraskeletal Myxoid
Czasopismo naukowe
Tytuł :
Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).
Autorzy :
Yang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Zhang X; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Zhang J; Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Gao J; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Bai Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Deng W; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Chen G; Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
An Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Liu Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Wei Q; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
Han J; Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Li A; Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing, China.
Liu G; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Sun Y; Department of Anorectal, Tianjin People's Hospital, Tianjin, China.
Kong D; Department of Colorectal Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yao H; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China. .
Zhang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2022 Apr 27; Vol. 22 (1), pp. 462. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Neoadjuvant Therapy*/adverse effects
Neoplasms, Second Primary*/therapy
Rectal Neoplasms*/pathology
Rectal Neoplasms*/therapy
Antibodies, Monoclonal, Humanized ; Carcinoma, Transitional Cell ; Clinical Trials, Phase II as Topic ; Female ; Humans ; Male ; Multicenter Studies as Topic ; Prospective Studies ; Urinary Bladder Neoplasms
Czasopismo naukowe
Tytuł :
NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy.
Autorzy :
Fan T; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.; Department of Oral and Maxillofacial Surgery, Zhang Zhiyuan Academician Workstation, Hainan Western Central Hospital, Shanghai Ninth People's Hospital, Danzhou, Hainan, China.; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Wang X; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.; Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang S; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Deng P; Department of Occupational Health, Third Military Medical University, Chongqing, China.
Jiang Y; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Liang Y; School of Medicine, Guangxi University, Nanning, Guangxi Zhuang Autonomous Region, China.
Jie S; Department of Occupational Health, Third Military Medical University, Chongqing, China.
Wang Q; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Li C; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.
Tian G; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.
Zhang Z; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.
Ren Z; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.; Department of Oral and Maxillofacial Surgery, Zhang Zhiyuan Academician Workstation, Hainan Western Central Hospital, Shanghai Ninth People's Hospital, Danzhou, Hainan, China.
Li B; Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China.
Chen Y; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
He Z; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Luo Y; Department of Occupational Health, Third Military Medical University, Chongqing, China.
Chen M; Institute of Pathology and Southwest Cancer Centre, Southwest Hospital, Third Military Medical University, Chongqing, China.
Wu H; Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Yu Z; Department of Occupational Health, Third Military Medical University, Chongqing, China.
Pi H; Department of Occupational Health, Third Military Medical University, Chongqing, China. .
Zhou Z; Department of Emergency Medicine, First Affiliated Hospital and Department of Environmental Medicine, School of Public Health, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. .
Zhang Z; Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China. .
Pokaż więcej
Źródło :
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2022 Apr 25; Vol. 7 (1), pp. 130. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji :
Journal Article
MeSH Terms :
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors*/genetics
Basic Helix-Loop-Helix Transcription Factors*/genetics
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/metabolism
Head and Neck Neoplasms*/pathology
Neoplasm Proteins*/genetics
Squamous Cell Carcinoma of Head and Neck*/genetics
Squamous Cell Carcinoma of Head and Neck*/metabolism
Squamous Cell Carcinoma of Head and Neck*/pathology
Autophagy/genetics ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/metabolism ; Carcinoma, Squamous Cell/pathology ; Cell Proliferation/genetics ; Humans ; Mouth Neoplasms/genetics ; Mouth Neoplasms/metabolism ; Mouth Neoplasms/pathology ; Nuclear Proteins ; Proteomics
Czasopismo naukowe
Tytuł :
Macrophage-Secreted S100A4 Supports Breast Cancer Metastasis by Remodeling the Extracellular Matrix in the Premetastatic Niche.
Autorzy :
Qi Y; Cancer Therapy and Research Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021 Shandong, China.
Zhao T; Cancer Therapy and Research Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021 Shandong, China.
Li R; Cancer Therapy and Research Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021 Shandong, China.
Han M; Cancer Therapy and Research Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021 Shandong, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2022 Apr 20; Vol. 2022, pp. 9895504. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/pathology
Lung Neoplasms*/secondary
Neoplasms, Second Primary*
Extracellular Matrix/pathology ; Female ; Humans ; Macrophages/pathology ; Melanoma ; S100 Calcium-Binding Protein A4/genetics ; Skin Neoplasms ; Tumor Microenvironment
SCR Disease Name :
Melanoma, Cutaneous Malignant
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies